Blueberries Medical Corp (OTCMKTS: BBRRF) is back in the news. With the recent development, the group is believed to have left rivals thinking.
The corporate house announced that one of its subsidiaries has successfully exported an overall 150 kg of premium CBD
Blueberries Medical Corp went on record and confirmed that Blueberries SAS, which is one of the 100% subsidiaries that the company owns, has created a history of sorts. The company stated that its subsidiary has successfully exported about 150 kg of CBD in the premium category 5% Full Spectrum Oil. The consignment was reportedly shipped to Futura Farms Peru, one of the leading licensed distributors operating in the Peruvian market.
Group has created history with the respective sale
Sources following the sales of the group and its subsidiaries stated that with this particular sale, Blueberries Medical Corp and its subsidiary Blueberries SAS have created history of sorts. The company started operating in 2018. According to the records held by the group, this respective sale is the biggest in terms of volume and cash.
Futura Farms is involved in developing solutions that will be distributed to pharmaceutical groups
Therefore, only those establishments that meet the Good Storage Practices (GSP) protocol will be considered to receive the compounding formulations developed by Futura Farms. The Good Storage Practices (GSP) requirements are issued by Peru’s General Directorate of Medicines, Supplies, and Drugs (DIGEMID). Considering the size and volume of the recent export, according to the calculations made by Blueberries Medical Corp, as many 2,500 patients will be beneficiaries from the finished solutions.
Blueberries Medical Corp has achieved its short-term goal
The Chief Executive Officer and Chairman of the Board of Blueberries Medical Corp, Facundo Garreton, against the backdrop of the recent record shipment, said that the group has successfully achieved its short-term goal. He added that the company now aims to generate seven times more revenue than it did in comparison to last year’s earnings. The Chief Executive Officer and Chairman of the Board added that the money generated through the sale would help the company is expanding to the next level by investing in equipment, applying for certification, among other things. In addition, Garreton hinted that the group is eying international markets.
Molson Coors Beverage Company (NYSE: TAP) and Hexo Corp’s (NASDAQ: HEXO) Joint Venture Truss CBD USA Expands Veryvell line
Post Views: 25 Molson Coors Beverage Company (NYSE: TAP) and Hexo Corp’s (NASDAQ: HEXO) subsidiary, HEXO USA Inc.’s joint venture...
PAO Group Inc. (OTCMKTS: PAOG) Exploring M&A Opportunities to Expand CBD Neutraceutical Product Line and Grow Revenue
Post Views: 25 PAO Group Inc. (OTCMKTS: PAOG) has announced that it is exploring M&A prospects targeted at expanding its...
Innovative Industrial Properties Inc. (NYSE: IIP) Announces Its Q3 2021 Operating, Capital Markets, and Investment Milestones
Post Views: 37 Innovative Industrial Properties Inc. (NYSE: IIP) has announced its July-to-date operating, capital markets, and investment activity. IIP...
Tilray Inc. (NASDAQ: TLRY) Reports 43% YoY Net Revenue Growth In Q1 2022
Post Views: 3 Tilray Inc. (NASDAQ: TLRY) has reported its Q1 2022 financial results in which the cannabis cultivator’s net...
Heritage Cannabis Holdings Corp (OTCMKTS: HERTF) Signs Supply Agreements With Australian Firms for CBD Filmstrips
Post Views: 6 Heritage Cannabis Holdings Corp (OTCMKTS: HERTF) has announced the signing of two supply deals with two established...
Amyris Inc. (NASDAQ: AMRS) Announce Licensing Of Inscripta’s Onyx Genome Engineering Platform
Post Views: 8 Amyris Inc. (NASDAQ: AMRS) has announced the licensing of the Onyx genome engineering platform from gene editing...